GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
3.960
-0.020 (-0.50%)
At close: Jan 16, 2026, 4:00 PM EST
3.890
-0.070 (-1.77%)
After-hours: Jan 16, 2026, 6:37 PM EST
GlucoTrack Employees
GlucoTrack had 11 employees as of December 31, 2024. The number of employees increased by 5 or 83.33% compared to the previous year.
Employees
11
Change (1Y)
5
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,350,364
Market Cap
3.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11 | 5 | 83.33% |
| Dec 31, 2023 | 6 | 3 | 100.00% |
| Dec 31, 2022 | 3 | -2 | -40.00% |
| Dec 31, 2021 | 5 | -6 | -54.55% |
| Dec 31, 2020 | 11 | 4 | 57.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GCTK News
- 18 days ago - Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - GlobeNewsWire
- 2 months ago - Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Glucotrack, Inc. Encourages Shareholders to Vote - GlobeNewsWire
- 2 months ago - Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - GlobeNewsWire
- 2 months ago - Glucotrack, Inc. Reminds Shareholders to Vote - GlobeNewsWire
- 4 months ago - Glucotrack to Participate in the Q3 Virtual Investor Summit - GlobeNewsWire
- 5 months ago - Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 months ago - Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology - GlobeNewsWire